ELSE NUTRITION HOLDINGS INC.
(BABY)
(BABYF)
(0YL.F) (“Else” or
the
“Company”) is proud to announce the
official commercial launch of its first-in-class ‘Follow-On’
formula for infants ages 6-12 months in Australia. The commercial
launch of the Follow-On formula for infants in Australia is a
significant milestone as it marks the first country, along with New
Zealand, in which the Company’s new infant formula is eligible for
sale. In addition, the Company announces the launch of its Toddler
Drink for toddlers ages 12-36 months in Australia.
The Australian market was strategically selected
due to its location in the Asia-Pacific region as a kickoff for a
planned expansion of the Company’s entire product line across the
region. According to Research and Markets, the Asia Pacific (APAC)
baby, infant and toddler food market is expected to grow from an
estimated market size of US$50 billion in 2021 to over US$75
billion in 2028.
Both products are now available on Amazon in
Australia, and plans are in place to roll them out through other
online retailers and brick-and-mortar retail locations. These
products that use innovative plant-based ingredients were produced
by Else’s partner production site in Europe, adhering to stringent
quality standards.
Else’s plant-based formula, which received the
Clean Label Project Purity Award, addresses an unmet need in the
infant formula market, which according to Fortune Business
Insights, is projected to grow from $71.83 billion in 2023 to
$141.70 billion by 2030.
Else’s infant formula meets strict regulatory
and nutritional standards based on human-milk nutritional gold
standards, which all infant formula must meet, including ratio
standards for amino acids, fatty acids, and macronutrients, setting
a new bar for quality in the infant nutrition sector. Else's
plant-based infant formula also addresses consumer concerns about
processed ingredients, major allergens, and potential residues
found in standard dairy-based formulas.
In contrast, current core ingredients in
standard infant formulas are ultra-processed, often leading to
undesired symptoms. Current dairy formulas, which represent
approximately 95% of the market, have shown certain side effects in
many infants and their main ingredients are major allergens, with
additional concerns related to antibiotics, hormones and other
undesired materials, as well as animal welfare and environmental
considerations. Moreover, these dairy formula ingredients cannot
stay in their whole form due to the need to use fractionated
ingredients in order to meet the desired nutritional composition,
and they must use highly processed derivatives. Furthermore, soy
protein formulas, which account for about 5% of the market,
frequently generate similar side effects and contain high levels of
phytoestrogens as well as GMOs. Similar to dairy formulas, soy
protein formulas cannot stay in their whole form as they require
fractionated ingredients in order to meet the required nutritional
values. The protein must be isolated and chemically processed with
solvents, and the fats and carbohydrates are also considered
ultra-processed foods.
Else’s infant formula is free of antibiotics,
hormones, pesticides, GMOs, and heavy metals – all of which are an
increasing concern among parents. The core ingredients, almonds,
buckwheat, and tapioca, have a ~65% lower carbon footprint and
require zero chemical processing, keeping proteins intact. The
Company’s infant formula is meticulously crafted to support infants
aged 6-12 months as they transition to solid foods, ensuring they
receive essential nutrients for optimal growth and development.
Hamutal Yitzhak, CEO and Co-Founder of Else
Nutrition, stated, “We are extremely proud to officially launch our
infant formula and our toddler drink in Australia, serving as a
beachhead for the planned global expansion of our range of
breakthrough products.
This first-in-class infant product is designed
to provide infants with a more nutritious, healthier, and safer
alternative.”
“We selected Australia after a meticulous
evaluation of the regulatory framework and were deemed in
compliance. Australia is widely recognized for its rigorous health
and other regulatory standards. In addition, Australia is
strategically located in the Asia Pacific region, which we envision
will be an ideal market from which to expand our other line of
products across the region. The Asia Pacific region represents an
extremely large addressable market, desiring safe and high-quality
Western products, especially in the children’s health and nutrition
categories. Our strategic focus is on
establishing partnerships in this region to support our
expansion efforts.”
“We are delighted to work with Amazon in
Australia and look forward to expanding our footprint through
additional retail and online distribution channels, as we have
demonstrated in North America. We are on a mission to revolutionize
infant and toddler nutrition by providing products that meet the
needs of families seeking clean-label alternatives based on dairy
and soy-free, whole-plant, minimally processed ingredients,”
concluded Ms. Yitzhak.
For more information and updates on
availability, visit www.elsenutrition.au.
About Else Nutrition Holdings
Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX:
BABYF, FSE: 0YL) is a food and nutrition company in the
international expansion stage focused on developing innovative,
clean, and Plant-Based food and nutrition products for infants,
toddlers, children, and adults. Its revolutionary, Plant-Based,
non-soy formula is a clean-ingredient alternative to dairy-based
formulas. Since launching its Plant-Based Complete Nutrition for
Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the
brand has received thousands of powerful testimonials and reviews
from parents, gained national retailer support, and achieved rapid
sales growth.
Awards and Recognition:
- "2017 Best Health and Diet
Solutions" award at Milan's Global Food Innovation Summit
- #1 Best Seller on Amazon in the
Fall of 2020 in the New Baby & Toddler Formula Category
- “Best Dairy Alternative” Award 2021
at World Plant-Based Expo
- Nexty Award Finalist at Expo West
2022 in the Plant-Based lifestyle category
- During September 2022, Else Super
Cereal reached the #1 Best Seller in Baby Cereal across all brands
on Amazon
Investor Relations Contact:
Alexandra SchiltCrescendo
Communications, LLCOffice: (212) 671-1020
Email: baby@crescendo-ir.com
TSX
Neither the TSX nor its regulation services
provider (as that term is defined in the policies of the TSX)
accept responsibility for the adequacy or accuracy of this
release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the company's financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs, and assumptions,
which are based on management's perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID-19 and that the
manufacturing, broker, and supply logistic agreement with the
company does not terminate. Actual results may differ from the
estimates, beliefs, and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management's expectations only as of the date of this press
release. The company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law.
A photo accompanying this announcement is
available
at:https://www.globenewswire.com/NewsRoom/AttachmentNg/0cc01f35-e284-4bbc-bbe2-197c71ab7c0f
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025